Oncolysis of pancreatic tumour cells by a γ34.5-deleted HSV-1 does not rely upon Ras-activation, but on the PI 3-kinase pathway

This publication has 28 references indexed in Scilit:

• Viruses with deletions in antiapoptotic genes as potential oncolytic agents
  Oncogene, 2005
• Development of gene therapy to target pancreatic cancer
  Cancer Science, 2004
• Genetic profile of 22 pancreatic carcinoma cell lines
  Virchows Archiv, 2001
• Oncogenes in Ras signalling pathway dictate host-cell permissiveness to herpes simplex virus 1
  Nature Cell Biology, 2001
• Reovirus Therapy of Tumors with Activated Ras Pathway
  Science, 1998
• The Double-Stranded RNA-Dependent Protein Kinase PKR: Structure and Function
  Journal of Interferon & Cytokine Research, 1997
• The γ ₁ 34.5 protein of herpes simplex virus 1 complexes with protein phosphatase 1α to dephosphorylate the α subunit of the eukaryotic translation initiation factor 2 and preclude the shutoff of protein synthesis by double-stranded RNA-activated protein kinase
  Proceedings of the National Academy of Sciences, 1997
• Monthly Update: Oncologic, Endocrine & Metabolic: Replicating oncolytic viruses: An overview
  Expert Opinion on Investigational Drugs, 1996
• Endogenous inhibitors of the dsRNA-dependent eIF-2α protein kinase PKR in normal and ras-transformed cells
  Biochimie, 1994
• Most human carcinomas of the exocrine pancreas contain mutant c-K-ras genes
  Published by Elsevier ,1988